Drug Corporations Kick Lobbying into High Gear to Stop Medicare Drug Price Negotiation

October 12, 2021 Drug Corporations Kick Lobbying into High Gear to Stop Medicare Drug Price Negotiation Millions of dollars in advertising, funded by pharmaceutical corporations and business organizations , are being spent to block President Biden’s Build Back Better plan, and the provision allowing Medicare to negotiate lower drug prices and expand benefits is a focus of many of those ads.

Read the source article at Home – Retired Americans
2021-10-12 22:08:21